Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01185 (
vasopressin
)
23,126
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The development of blood pressure was monitored by the tail-cuff method in normotensive (WKY) and stroke-prone spontaneously hypertensive rats (SHRSP) receiving
ethanol
(alcohol) in drinking water from weaning (approximately 1 month of age).
Alcohol
administration over a 3-month period attenuated the development of hypertension in SHRSP and also caused a small reduction of the initial blood pressure rise in WKY. This was accompanied by a reduction of fluid intake and an increase of circulating
antidiuretic hormone
(arginine vasopressin; AVP). Circulatory volume remained constant. Direct measurement of arterial blood pressure in conscious rats before and after autonomic blockade confirmed the antihypertensive effect of alcohol in SHRSP and indicated that it is at least partly dependent on altered activity of neural mechanisms. Sudden withdrawal of alcohol caused an immediate increase of fluid intake followed by a rise of blood pressure lasting several days in both WKY and SHRSP. This withdrawal hypertension could not be attributed to changes in plasma catecholamines or AVP.
...
PMID:Effects of chronic alcohol consumption and alcohol withdrawal on blood pressure in stroke-prone spontaneously hypertensive rats. 276 25
Serotonin-stimulated activation of phospholipase C in primary astroglial cell cultures was studied as a mean of evaluating the effect of acute
ethanol
exposition on this signal transduction system. The addition of 50-150 mM
ethanol
prior to stimulation with 10(-5) M serotonin led to a potentiation of the serotonin-induced [3H]-inositol phosphate formation and an increased incorporation of [3H]-inositol into the three phosphoinositides studied. This potentiating effect of
ethanol
was observed only when
ethanol
was added together with serotonin. No stimulatory effect of
ethanol
per se was found. Furthermore,
ethanol
had no effect on
arginine-vasopressin
, bradykinin or phenylephrine stimulated inositol lipid metabolism.
...
PMID:Ethanol potentiates serotonin stimulated inositol lipid metabolism in primary astroglial cell cultures. 277 5
Absorption of glycine solution during transurethral resection of the prostate (TURP) changes the serum concentrations of most non-essential amino acids and inhibits diuresis by stimulating release of
vasopressin
.
Ethanol
was used as a marker to detect the absorption of irrigant. Measurements of the serum concentrations of
vasopressin
and amino acids were made in eight patients with absorption volumes from 427 to 1906 ml.
Ethanol
did not alleviate the
vasopressin
response to glycine absorption, but changes in the amino acid concentrations in serum became less pronounced than when glycine alone was used.
...
PMID:Vasopressin and amino acid concentrations in serum following absorption of irrigating fluid containing glycine and ethanol. 280 91
We have previously demonstrated that single-dose
ethanol
administration enhanced plasma levels of ACTH, beta-endorphin, corticosterone (CS) and catecholamines. Since the secretion of proopiomelanocortin-derived peptides (e.g., ACTH, beta-endorphin) can be influenced by catecholamines and
vasopressin
in addition to the primary physiological regulator, corticotrophin-releasing hormone, we have attempted to determine whether or not the
ethanol
-induced activation of the hypothalamic-pituitary-adrenal axis (HPAA) could in part be mediated via either epinephrine or
vasopressin
(AVP) secretion. The selective neutralization of AVP through the administration of AVP antiserum failed to block the
ethanol
-induced secretion of either ACTH or CS. In addition, adrenal demedullation did not significantly attenuate the
ethanol
-induced increase of ACTH and CS. It would appear that neither adrenal medulla-derived epinephrine nor median eminence-derived AVP mediates
ethanol
's activation of the HPAA.
Adv
Alcohol
Subst Abuse 1988
PMID:Acute effect of intragastric ethanol administration on plasma levels of stress hormones. 285 31
The role of Ca2+ in stimulation of the malate-aspartate shuttle by norepinephrine and
vasopressin
was studied in perfused rat liver. Shuttle capacity was indexed by measuring the changes in both the rate of production of glucose from sorbitol and the ratio of lactate to pyruvate during the oxidation of
ethanol
. (T. Sugano et al. (1986) Amer. J. Physiol. 251, E385-E392). Asparagine (0.5 mM), but not alanine (0.5 mM) decreased the
ethanol
-induced responses. Norepinephrine and
vasopressin
had no effect on the
ethanol
-induced responses when the liver was perfused with sorbitol or glycerol. In the presence of 0.25 mM alanine, norepinephrine,
vasopressin
, and A23187 decreased the
ethanol
-induced responses that occurred with the increase of flux of Ca2+. In liver perfused with Ca2+-free medium, asparagine also decreased the
ethanol
-induced responses, but norepinephrine and
vasopressin
had no effect. Aminooxyacetate inhibited the effects of norepinephrine, A23187, and asparagine. Regardless of the presence or absence of perfusate Ca2+, the combination of glucagon and alanine had no effect on the
ethanol
-induced responses. Norepinephrine caused a decrease in levels of alpha-ketoglutarate, aspartate, and glutamate in hepatocytes incubated with Ca2+. The present data suggest that the redistribution of cellular Ca2+ may activate the efflux of aspartate from mitochondria in rat liver, resulting in an increase in the capacity of the malate-aspartate shuttle.
...
PMID:Ca2+-dependent activation of the malate-aspartate shuttle by norepinephrine and vasopressin in perfused rat liver. 289 18
The
neurohypophyseal
hormone arginine vasopressin (AVP) acts in the central nervous system (CNS) to maintain functional tolerance to several effects of
ethanol
. The ability of exogenous
vasopressin
(administered i.c.v.) to maintain tolerance to the hypnotic effect of
ethanol
was blocked more effectively by antagonists acting at V1 receptors than by a V2-selective antagonist. Similarly, a V1-selective agonist was more potent than AVP in maintaining tolerance, whereas V2-selective agonists were inactive. These results indicate that
vasopressin
maintains
ethanol
tolerance via an action at CNS receptors that have the characteristics of V1
vasopressin
receptors. Furthermore, a V1-selective antagonist, given alone, enhanced the rate of loss of tolerance, whereas a V2-selective antagonist did not, supporting a role for endogenous AVP, also acting at V1
vasopressin
receptors, in the maintenance of
ethanol
tolerance. Characterization of the CNS receptors that mediate the modulation of
ethanol
tolerance by
vasopressin
suggests a mechanism of action of the peptide hormone in the CNS, and may contribute to the eventual development of therapies to modify functional
ethanol
tolerance.
...
PMID:Receptors with V1 characteristics mediate the maintenance of ethanol tolerance by vasopressin. 297 30
Alcohol
or drug tolerance has been viewed traditionally as a homeostatic response to a direct chemical action of the agent on the neuron. This concept has undergone major modification as a result of recent observations that behavioral and environmental factors can alter markedly the tolerance developed to the same drug regimen. Obligatory task performance under the influence of the drug, classical conditional stimuli in an environment habitually associated with drug administration, previous exposure to a tolerance-producing regimen, and environmental modification of the expression of the drug's effect can all influence dramatically the degree of tolerance produced by a given dosage. Attempts to identify possible cellular mechanisms of tolerance development are illustrated by a review of studies on the relations between
ethanol
tolerance and changes in the neuronal membrane Na+ -K+ ATPase and its interaction with
ethanol
and norepinephrine, hippocampal serotoninergic systems and their interaction with a
vasopressin
derivative, a membrane-bound calcium- and calmodulin- dependent kinase, and hypothalamic-hypophyseal endorphin-producing systems. None of these studies or other similar ones, whether correlational or interventional in nature, has yet provided full and credible explanations of the effects of behavioral and environmental factors on tolerance development. Finding such explanations is the major current challenge in the neurobiology of tolerance.
...
PMID:The 1985 Upjohn award lecture. Tolerance, learning, and neurochemical adaptation. 300 93
Although acute administration of
ethanol
in vivo results in increased plasma glucocorticoid concentration, it is unclear whether this effect is mediated by corticotropin (ACTH) from the anterior pituitary. Secretion of beta-endorphin-like (BE-IR) and corticotropin-like (ACTH-IR) immunoreactivity from perifused, dispersed mouse adenohypophyseal cells was used to evaluate the effect of 17 mM
ethanol
on secretion of pituitary peptides. Cells were also exposed to 10 nM synthetic corticotropin-releasing factor (CRF), 1 microM
vasopressin
, 54 mM KCl, 100 nM corticosterone, and calcium-free medium, separately and in combination. Secretion of BE-IR and ACTH-IR were markedly sensitive to low concentrations of
ethanol
. Exposure to 17 mM
ethanol
produced 3-fold stimulation of the rate of hormone release. This represented one-third to two-thirds that of the rate of maximum stimulation by CRF. Unlike CRF-stimulated secretion,
ethanol
-stimulated secretion was transient. Further, a second
ethanol
exposure 1 h after the first did not stimulate peptide secretion. Similar to CRF-stimulation,
ethanol
-stimulated peptide secretion required extracellular calcium and was inhibited by the glucocorticoid corticosterone. We suggest that this system is a useful model for investigation of the actions of low concentrations of
ethanol
at the cellular level.
...
PMID:Ethanol-stimulated endorphin and corticotropin secretion in vitro. 300 21
A number of alcohol research groups have measured anterior and posterior pituitary hormones, the endogenous opiates, CNS peptides, and putative neurotransmitters during alcohol withdrawal. The data are often complex and contradictory, though a number of themes have emerged. Activity of the hypothalamic-pituitary-adrenal axis (HPA) is increased during chronic alcohol exposure and appears to remain altered for at least 2 to 4 weeks after cessation of drinking. There is increased turnover of norepinephrine and enhanced binding of CNS adrenergic receptors. By contrast, there are decreases in CNS activity of select endogenous opiates and GABA. Other CNS compounds that may play a role in alcohol withdrawal are prolactin, thyrotropin-releasing hormone (TRH),
vasopressin
, cyclic 3'5'-adenosine monophophate (cAMP), Delta-sleep-inducing peptide (DSIP), and iron. Despite many studies in humans and animals, the roles of CNS dopamine and serotonin in withdrawal remain unclear. A number of peptides, including cholecystokinin (CCK), neurotensin, and bombesin, have been shown to interact with the CNS actions of alcohol and may play a role in alcohol withdrawal. Inadequate work has been performed on acetylcholine (ACh), human growth hormone (HGH) and luteinizing hormone (LH). Studies of the recently identified GABA-benzodiazepine-barbituate receptor complex indicate that this system is likely to be involved in the pathophysiology of alcohol withdrawal. Perturbation studies with corticotropin-releasing factor (CRF) and TRH (with measures of ACTH and cortisol and TSH and prolactin, respectively), may identify patients with withdrawal-related autonomic dysfunction.
Recent Dev
Alcohol
1986
PMID:Clinical neuroendocrinology and neuropharmacology of alcohol withdrawal. 301 Mar 91
The effects of hormones on the cytochrome spectra of isolated hepatocytes were recorded under conditions of active gluconeogenesis from L-lactate. Glucagon, phenylephrine,
vasopressin
and valinomycin, at concentrations that caused stimulation of gluconeogenesis, increased the reduction of the components of the cytochrome bc1 complex, just as has been observed in liver mitochondria isolated from glucagon-treated rats [Halestrap (1982) Biochem. J. 204, 37-47]. The effects of glucagon and phenylephrine were additive. The time courses of the increased reduction of cytochrome c/c1 and NAD(P)H/NAD(P)+ caused by hormones, valinomycin, A23187 and
ethanol
were measured by dual-beam spectrophotometry and fluorescence respectively.
Ethanol
(14 mM) produced a substantial rise in NAD(P)H fluorescence, beta-hydroxybutyrate/acetoacetate and lactate/pyruvate ratios, no change in cytochrome c/c1 reduction, a 10% decrease in O2 consumption and a 60% decrease in gluconeogenesis. Glucagon, phenylephrine and
vasopressin
caused a substantial and transient rise in NAD(P)H fluorescence, but a sustained increase in cytochrome c/c1 reduction and the rates of O2 consumption and gluconeogenesis. The transience of the fluorescence response was greater in the absence of Ca2+, when the cytochrome c/c1 response also became transient. The fluorescence response was smaller and less transient, but the cytochrome c/c1 response was greater, in the presence of fatty acids. Both responses were greatly decreased by the presence of 1 mM-pent-4-enoate. Valinomycin (2.5 nM) caused a decrease in NAD(P)H fluorescence coincident with an increase in cytochrome c/c1 reduction and the rate of gluconeogenesis and O2 consumption. A23187 (7.5 mM) caused increases in both NAD(P)H fluorescence and cytochrome c/c1 reduction. The effects of hormones and valinomycin on the time courses of NAD(P)H fluorescence, cytochrome c/c1 reduction and light-scattering by hepatocytes were compared with those of 0.5 microM-Ca2+ or 1 nM-valinomycin on the same parameters of isolated liver mitochondria. It is concluded that hormones increase respiration by hepatocytes in a biphasic manner. An initial Ca2+-dependent activation of mitochondrial dehydrogenases rapidly increases the mitochondrial [NADH], which is followed by a volume-mediated stimulation of fatty acid oxidation and electron flow between NADH and cytochrome c. 10. Amytal (0.5 mM) was able to reverse the effects of hormones on the reduction of cytochromes c/c1 and the rates of gluconeogenesis and O2 consumption without significantly lowering tissue [ATP].(ABSTRACT TRUNCATED AT 400 WORDS)
...
PMID:The mechanism of the hormonal activation of respiration in isolated hepatocytes and its importance in the regulation of gluconeogenesis. 302 26
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>